Systematic review of worldwide trends in assisted reproductive technology, Reprod Biol Endocrinol, vol.15, 2004. ,
Improving the luteal phase after ovarian stimulation: reviewing new options, Reproductive BioMedicine Online, vol.28, p.24656557, 2014. ,
Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening, Molecular Human Reproduction, vol.8, p.12200466, 2002. ,
The progesterone receptor regulates implantation, decidualization, and glandular development via a complex paracrine signaling network, Mol Cell Endocrinol, vol.357, p.22115959, 2012. ,
Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization, J Clin Endocrinol Metab, vol.87, p.11836309, 2002. ,
Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles, Reprod Biomed Online, vol.36, p.29550390, 2018. ,
Luteal phase support for assisted reproduction cycles, Cochrane Database Syst Rev, vol.009154, p.26148507, 2015. ,
Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study, Hum Reprod, vol.32, p.29040638, 2017. ,
Mid-luteal serum progesterone concentrations govern implantation rates for cryopreserved embryo transfers conducted under hormone replacement, Reprod Biomed Online, vol.31, p.26099447, 2015. ,
Progesterone levels on pregnancy test day after hormone replacement therapy-cryopreserved embryo transfer cycles and related reproductive outcomes, Reprod Biomed Online, vol.37, p.30385142, 2018. ,
The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF/ICSI cycles, Hum Reprod, 2018. ,
, , p.29955789
Low as well as high serum P4 levels in the early and mid-luteal phase reduce the chance of a live birth following IVF treatment with fresh embryo transfer: where is the evidence?, Hum Reprod, vol.33, p.30325399, 2018. ,
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization, Hum Reprod, vol.32, pp.1019-1027, 2017. ,
V. film-coated tablets 10 mg Summary of Product Characteristics, 2017. ,
URL : https://hal.archives-ouvertes.fr/in2p3-00123118
Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard?, Fertil Steril, vol.109, p.29778368, 2018. ,
Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction, Reprod Biomed Online, vol.38, p.30595525, 2019. ,
Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study, J Steroid Biochem Mol Biol, vol.97, p.16213136, 2005. ,
Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone, Gynecol Endocrinol, vol.23, issue.1, p.17943542, 2007. ,
Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study, Fertil Steril, vol.95, p.21333984, 2011. ,
Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial, Eur J Obstet Gynecol Reprod Biol, vol.186, p.25622239, 2015. ,
A comparative study of dydrogesterone and micronized progesterone for luteal phase support during in vitro fertilization (IVF) cycles, Gynecol Endocrinol, vol.32, p.26486011, 2016. ,
Determination of Dydrogesterone in Human Plasma by Tandem Mass Spectrometry: Application to Therapeutic Drug Monitoring of Dydrogesterone in Gynecological Disorders, Chroma, vol.64, pp.287-292, 2006. ,
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation, Fertil Steril, vol.108, p.28697910, 2017. ,
New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles, Hum Reprod, vol.33, p.29300975, 2018. ,
Dangers of using "optimal" cutpoints in the evaluation of prognostic factors, J Natl Cancer Inst, vol.86, p.8182763, 1994. ,
Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients, Fertil Steril, vol.109, p.29935655, 2018. ,
Progesterone pharmacokinetics and pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized progesterone vaginal insert, J Clin Endocrinol Metab, vol.99, p.24606090, 2014. ,
Direct transport of progesterone from vagina to uterus, Obstet Gynecol, vol.95, p.10711552, 2000. ,
Experience with a novel vaginal progesterone preparation in a donor oocyte program, Fertil Steril, vol.69, p.9457941, 1998. ,